Pseudomonas aeruginosa PA7 is an obligate aerobe, mesophilic, Gram-negative human pathogen that has multiple antibiotic resistances and was isolated from outer ear infection.
antibiotic resistance Gram-negative motile rod-shaped obligate aerobe mesophilic human pathogen genome sequence 16S sequence
SI-ID 3893
| @ref 20215 |
|
Last LPSN update
2025-12-16 09:49:55 |
| Domain Pseudomonadati |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Pseudomonadaceae |
| Genus Pseudomonas |
| Species Pseudomonas aeruginosa |
| Full scientific name Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 572 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 572 | NUTRIENT AGAR (DSMZ Medium 1) | Medium recipe at MediaDive | Name: NUTRIENT AGAR (DSMZ Medium 1) Composition: Agar 15.0 g/l Peptone 5.0 g/l Meat extract 3.0 g/l Distilled water | ||
| 41819 | MEDIUM 72- for trypto casein soja agar | Distilled water make up to (1000.000 ml);Trypto casein soy agar (40.000 g) | |||
| 572 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water | ||
| 116095 | CIP Medium 72 | Medium recipe at CIP | |||
| 116095 | CIP Medium 3 | Medium recipe at CIP |
| Test 1 | Test 2 | Test 3 | Test 4 | Test 5 | Test 6 | Test 7 | Test 8 | Test 9 | Test 10 | Test 11 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| @ref | 572 | 572 | 572 | 572 | 572 | 572 | 572 | 572 | 572 | 572 | 572 |
| Medium | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller Hinton | Müller-Hinton Agar | Müller-Hinton Agar |
| Manual annotation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 24 | 28 | 26 | 24-26 | 24-26 | 26 | 26 | 26 | 24 | 28 | 26-28 |
| Ampicillin 10µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aztreonam 30µg (disc) | 28-30 | 30 | 30 | 30 | 30 | 30 | 28 | 28 | 28 | 30 | 30 |
| Bacitracin 10Unit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | n.d. | n.d. |
| Cefalotin 30µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | n.d. | n.d. |
| Cefazolin 30µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | n.d. | n.d. |
| Cefiderocol 30µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 38-40 | 38 |
| Cefotaxime 30µg (disc) | 24 | 22-24 | 24 | 24 | 22 | 26 | 22 | 22 | 22-24 | 24 | 24 |
| Ceftazidime 10µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 30 | 28 |
| Ceftriaxone 30µg (disc) | 24 | 24 | 24 | 24 | 24 | 26 | 20 | 20 | 24 | 28 | 24-26 |
| Chloramphenicol 30µg (disc) | 10 | 12 | 12 | 16-18 | 12 | 12 | 10 | 10 | 14 | 0 | 14 |
| Ciprofloxacin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 38 | 36 |
| Clindamycin 10µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 |
| Colistin 10µg (disc) | 14 | 16 | 14 | 14 | 14-16 | 12-14 | 14 | 14 | 14 | n.d. | n.d. |
| Colistin sulphate 10µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 16 | 16 |
| Doxycycline 30µg (disc) | 10 | 10 | 10 | 8 | 8 | 6 | 8 | 8 | 6 | n.d. | n.d. |
| Erythromycin 15µg (disc) | 8 | 8 | 10 | 18 | 6 | 10 | 6 | 6 | 0 | 0 | 0 |
| Fosfomycin 50µg (disc) | 36 | 36 | 36 | 36-38 | 36-38 | 36 | 32-34 | 32-34 | 34 | 36-38 | 34 |
| Gentamicin 30µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 22-24 | 26 |
| Gentamycin 10µg (disc) | n.d. | n.d. | |||||||||
| Imipenem 10µg (disc) | 28 | 28 | 26-28 | 28 | 28-30 | 28 | 26 | 26 | 28 | 30-32 | 26 |
| Kanamycin 30µg (disc) | 12 | 12-14 | 12 | 12 | 26 | 14 | 10-12 | 10-12 | 10 | 10 | 12 |
| Levofloxacin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 30 | 30 |
| Lincomycin 15µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | n.d. | n.d. |
| Linezolid 10µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
| Meropenem 10µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 40 | 38 |
| Mezlocillin 30µg (disc) | 20 | 20 | 20 | 20-22 | 20 | 22 | 20 | 20 | 18 | n.d. | n.d. |
| Moxifloxacin 5µg (disc) | 24 | 24 | 24 | 24 | 24 | 24 | 20-22 | 20-22 | 22 | 24 | 24 |
| Neomycin 30µg (disc) | 18 | 18 | 18 | 16-18 | 18 | 18 | 18 | 18 | 18 | n.d. | n.d. |
| Nitrofurantoin 100µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Norfloxacin 10µg (disc) | 30 | 30-32 | 32 | 30 | 32 | 30 | 30 | 30 | 30 | n.d. | n.d. |
| Nystatin 100Unit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | n.d. | n.d. |
| Ofloxacin 5µg (disc) | 24 | 26 | 24 | 24-26 | 24 | 24 | 24 | 24 | 22 | 24-26 | 26 |
| Oxacillin 5µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Penicillin G 6µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pipemidic acid 20µg (disc) | 16 | 18 | 16-18 | 16-18 | 18 | 16 | 14 | 14 | 14 | n.d. | n.d. |
| Piperacillin/Tazobactam 40µg (disc) | 28 | 28 | 26 | 26-28 | 28 | 28 | 26-28 | 26-28 | 26 | n.d. | n.d. |
| Piperacillin/Tazobactam 110µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 30 | 34 |
| Polymyxin B 300Unit | 16 | 18 | 16 | 14-16 | 14-16 | 16 | 16 | 16 | 16 | 18 | 18 |
| Quinupristin/Dalfopristin 15µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Rifampicin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 6 | 6 |
| Teicoplanin 30µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tetracycline 30µg (disc) | 12 | 12-14 | 12 | 12 | 12 | 10 | 8-10 | 8-10 | 10 | 12-14 | 14 |
| Ticarcillin 75µg (disc) | 28 | 28 | 28-30 | 28 | 28 | 28-30 | 26-28 | 26-28 | 26-28 | 28 | 28 |
| Tigecycline 15µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 8 | 12 |
| Trimethoprim-sulfamethoxazole (1:19) 10µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 18 | 0 |
| Vancomycin 30µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| @ref | Spore formation | Confidence | |
|---|---|---|---|
| 125439 | 99.1 |
| 572 | Compoundrhamnolipid |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68369 | 17128 ChEBI | adipate | + | assimilation | from API 20NE |
| 68369 | 29016 ChEBI | arginine | + | hydrolysis | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | + | assimilation | from API 20NE |
| 68369 | 16899 ChEBI | D-mannitol | + | assimilation | from API 20NE |
| 68369 | 16024 ChEBI | D-mannose | - | assimilation | from API 20NE |
| 68369 | 27689 ChEBI | decanoate | + | assimilation | from API 20NE |
| 68369 | 4853 ChEBI | esculin | - | hydrolysis | from API 20NE |
| 68369 | 5291 ChEBI | gelatin | + | hydrolysis | from API 20NE |
| 68369 | 24265 ChEBI | gluconate | + | assimilation | from API 20NE |
| 68369 | 30849 ChEBI | L-arabinose | - | assimilation | from API 20NE |
| 68369 | 25115 ChEBI | malate | + | assimilation | from API 20NE |
| 68369 | 17306 ChEBI | maltose | - | assimilation | from API 20NE |
| 68369 | 59640 ChEBI | N-acetylglucosamine | + | assimilation | from API 20NE |
| 116095 | 17632 ChEBI | nitrate | + | reduction | |
| 116095 | 16301 ChEBI | nitrite | + | reduction | |
| 68369 | 27897 ChEBI | tryptophan | - | energy source | from API 20NE |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 572 | 28971 | Ampicillin | 10 µg (disc) | from Antibiotic test | |
| 572 | 28669 | Bacitracin | 10 Unit | from Antibiotic test | |
| 572 | 124991 | Cefalotin | 30 µg (disc) | from Antibiotic test | |
| 572 | 474053 | Cefazolin | 30 µg (disc) | from Antibiotic test | |
| 572 | 6472 | Lincomycin | 15 µg (disc) | from Antibiotic test | |
| 572 | 71415 | Nitrofurantoin | 100 µg (disc) | from Antibiotic test | |
| 572 | 7660 | Nystatin | 100 Unit | from Antibiotic test | |
| 572 | 7809 | Oxacillin | 5 µg (disc) | from Antibiotic test | |
| 572 | 18208 | Penicillin G | 6 µg (disc) | from Antibiotic test | |
| 572 | Quinupristin/Dalfopristin | 15 µg (disc) | from Antibiotic test | ||
| 572 | 29687 | Teicoplanin | 30 µg (disc) | from Antibiotic test | |
| 572 | 28001 | Vancomycin | 30 µg (disc) | from Antibiotic test |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 68369 | arginine dihydrolase | + | 3.5.3.6 | from API 20NE |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68369 | beta-glucosidase | - | 3.2.1.21 | from API 20NE |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 116095 | catalase | + | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 68369 | cytochrome oxidase | + | 1.9.3.1 | from API 20NE |
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 68369 | gelatinase | + | from API 20NE | |
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 68382 | lipase (C 14) | + | from API zym | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 116095 | oxidase | + | ||
| 68382 | trypsin | + | 3.4.21.4 | from API zym |
| 116095 | urease | - | 3.5.1.5 | |
| 68382 | valine arylamidase | - | from API zym |
Metadata FA analysis  | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| @ref | 47686 | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Metadata FA analysis | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| @ref | 47686 | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| @ref | Reduction of nitratesNO3 | TRP | GLU_ Ferm | ADH (Arg) | URE | ESC | GEL | PNPG | GLU_ Assim | ARA | MNE | MAN | NAG | MAL | GNT | CAP | ADI | MLT | CIT | PAC | OX | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 572 | - | - | - | + | +/- | - | + | - | + | - | - | + | + | - | + | + | + | + | + | - | + | |
| 572 | + | - | - | + | +/- | - | + | +/- | + | - | - | + | + | - | + | + | + | + | + | - | + | |
| 572 | + | - | - | + | - | - | + | - | + | - | - | + | + | - | + | + | + | + | + | - | + | |
| 47686 | + | - | + | + | + | - | + | - | + | - | - | + | + | - | + | + | + | + | + | - | + | |
| 572 | + | - | - | + | + | - | + | + | + | - | - | + | + | - | + | + | + | + | + | - | + | |
| 572 | - | - | +/- | + | + | - | + | - | + | - | - | + | + | - | + | + | + | + | + | - | + | |
| 572 | - | - | - | + | +/- | - | + | - | + | - | - | + | + | - | + | + | + | + | + | - | + |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM260181v1 assembly for Pseudomonas paraeruginosa ATCC 9027 | scaffold | GCA_002601815   | 287.4563  | 8011011055  | 2994495 | 66.95 | |
| 66792 | ASM256333v1 assembly for Pseudomonas paraeruginosa ATCC 9027 | contig | GCA_002563335 | 287.4560 | 2994495 | 66.08 | | |
| 66792 | 259_Rw151_contigs_500 assembly for Pseudomonas paraeruginosa ATCC 9027 | contig | GCA_001374975 | 287.1942 | 2731958027 | 2994495 | 65.21 | |
| 66792 | ASM129467v1 assembly for Pseudomonas paraeruginosa ATCC 9027 | contig | GCA_001294675 | 287.1867 | 2675903282 | 2994495 | 62.03 | |
| 66792 | ASM140295v1 assembly for Pseudomonas paraeruginosa ATCC 9027 | scaffold | GCA_001402955 | 287.1969 | 2645727823 | 2994495 | 45.68 | |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 20218 | Pseudomonas aeruginosa strain DSM 1128 16S ribosomal RNA gene, partial sequence | AF502423 | 322 |  | 287 | |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria. | Klose M, Weber L, Bachmann HS. | PLoS One | 10.1371/journal.pone.0331440 | 2025 | | |
| High-Throughput Short Sequence Typing Schemes for Pseudomonas aeruginosa and Stenotrophomonas maltophilia Pure Culture and Environmental DNA. | Bourdin T, Benoit ME, Bedard E, Prevost M, Quach C, Deziel E, Constant P. | Microorganisms | 10.3390/microorganisms12010048 | 2023 | | |
| Pseudomonas aeruginosa strains belonging to phylogroup 3 frequently exhibit an atypical quorum sensing response: the case of MAZ105, a tomato rhizosphere isolate. | Quiroz-Morales SE, Muriel-Millan LF, Ponce-Soto GY, Gonzalez-Valdez A, Castillo-Juarez I, Servin-Gonzalez L, Soberon-Chavez G. | Microbiology (Reading) | 10.1099/mic.0.001401 | 2023 | | |
| An Alternative Microbiological Validation for an Online Water Bioburden Analyzer. | Venhuizen OL, Martindale CE, Liew FJ, Cannon J, Samanta A, Scaramozzino MJ. | J AOAC Int | 10.1093/jaoacint/qsae050 | 2024 | | |
| Revealing bioremediation potential of novel indigenous bacteria from oil-contaminated sites in the UAE: A combined bioinformatics and experimental validation | Alkhatib S, Arya S, Islayem D, Nyadzayo R, Mohamed S, Yousef A, Hernandez H, Pappa A. | PLoS One | 2025 | | ||
| Insights into the metabolism, signaling, and physiological effects of 2',3'-cyclic nucleotide monophosphates in bacteria. | Marotta NJ, Weinert EE. | Crit Rev Biochem Mol Biol | 10.1080/10409238.2023.2290473 | 2023 | | |
| Cultivation | GVPC Medium Manufactured without Oxygen Improves the Growth of Legionella spp. and Exhibits Enhanced Selectivity Properties. | Casino P, Lopez A, Peiro S, Rios M, Rios S, Porta A, Agusti G, Asensio D, Marques AM, Pique N | Microbiol Spectr | 10.1128/spectrum.02401-21 | 2022 | |
| Antimicrobial potential of natural deep eutectic solvents. | Al-Akayleh F, Khalid RM, Hawash D, Al-Kaissi E, Al-Adham ISI, Al-Muhtaseb N, Jaber N, Al-Remawi M, Collier PJ | Lett Appl Microbiol | 10.1111/lam.13699 | 2022 | | |
| Removal of heavy oil from contaminated surfaces with a detergent formulation containing biosurfactants produced by Pseudomonas spp. | Farias CBB, Soares da Silva RCF, Almeida FCG, Santos VA, Sarubbo LA | PeerJ | 10.7717/peerj.12518 | 2021 | | |
| Chemical Profile of the Volatile Constituents and Antimicrobial Activity of the Essential Oils from Croton adipatus, Croton thurifer, and Croton collinus. | Cucho-Medrano JLL, Mendoza-Beingolea SW, Fuertes-Ruiton CM, Salazar-Salvatierra ME, Herrera-Calderon O | Antibiotics (Basel) | 10.3390/antibiotics10111387 | 2021 | | |
| Essential Oil and Hydrophilic Antibiotic Co-Encapsulation in Multiple Lipid Nanoparticles: Proof of Concept and In Vitro Activity against Pseudomonas aeruginosa. | Ben-Khalifa R, Gaspar FB, Pereira C, Chekir-Ghedira L, Rodriguez-Rojo S | Antibiotics (Basel) | 10.3390/antibiotics10111300 | 2021 | | |
| Behavior of Pseudomonas aeruginosa strains on the nanopillar topography of dragonfly (Pantala flavescens) wing under flow conditions. | Kamarajan BP, Ananthasubramanian M, Sriramajayam L, Boppe A | Biointerphases | 10.1116/6.0001303 | 2021 | | |
| Phylogeny | Biosynthesis of Selenium Nanoparticles (via Bacillus subtilis BSN313), and Their Isolation, Characterization, and Bioactivities. | Ullah A, Yin X, Wang F, Xu B, Mirani ZA, Xu B, Chan MWH, Ali A, Usman M, Ali N, Naveed M | Molecules | 10.3390/molecules26185559 | 2021 | |
| Vfr or CyaB promote the expression of the pore-forming toxin exlBA operon in Pseudomonas aeruginosa ATCC 9027 without increasing its virulence in mice. | Garcia-Reyes S, Moustafa DA, Attree I, Goldberg JB, Quiroz-Morales SE, Soberon-Chavez G | Microbiology (Reading) | 10.1099/mic.0.001083 | 2021 | | |
| Metabolism | PqsR-independent quorum-sensing response of Pseudomonas aeruginosa ATCC 9027 outlier-strain reveals new insights on the PqsE effect on RhlR activity. | Garcia-Reyes S, Cocotl-Yanez M, Soto-Aceves MP, Gonzalez-Valdez A, Servin-Gonzalez L, Soberon-Chavez G | Mol Microbiol | 10.1111/mmi.14797 | 2021 | |
| The Autofluorescence Patterns of Acanthamoeba castellanii, Pseudomonas aeruginosa and Staphylococcus aureus: Effects of Antibiotics and Tetracaine. | Peguda HK, Mahbub SB, Sherpa TD, Subedi D, Habibalahi A, Anwer AG, Gu Z, Willcox MDP, Goldys EM, Carnt NA | Pathogens | 10.3390/pathogens10070894 | 2021 | | |
| Determination of the Chemical Composition and Antimicrobial Activity of Lavatera thuringiaca L. Medicinal Herb Material Extracted under Subcritical Conditions by the Liquid Carbon Dioxide Method. | Zhandabayeva MA, Kozhanova KK, Boshkayeva AK, Kataev VA, Ustenova GO, Gemejiyeva NG, Iskakbayeva ZA | Int J Biomater | 10.1155/2021/7541555 | 2021 | | |
| Pathogenicity | Rational Design of Dipicolylamine-Containing Carbazole Amphiphiles Combined with Zn(2+) as Potent Broad-Spectrum Antibacterial Agents with a Membrane-Disruptive Mechanism. | Liu J, Li H, Li H, Fang S, Shi J, Chen Y, Zhong R, Liu S, Lin S | J Med Chem | 10.1021/acs.jmedchem.1c00858 | 2021 | |
| Pathogenicity | Anti-Pseudomonas aeruginosa biofilm activity of tellurium nanorods biosynthesized by cell lysate of Haloferax alexandrinus GUSF-1(KF796625). | Alvares JJ, Furtado IJ | Biometals | 10.1007/s10534-021-00323-y | 2021 | |
| In Vitro and In Vivo Evaluation of Silver Nanoparticles Phytosynthesized Using Raphanus sativus L. Waste Extracts. | Ungureanu C, Fierascu I, Fierascu RC, Costea T, Avramescu SM, Calinescu MF, Somoghi R, Pirvu C | Materials (Basel) | 10.3390/ma14081845 | 2021 | | |
| Impact of Spreading Time to Recovery Rate in Suitability Test of Solid Agar Media. | Teramura H, Yasuda E, Naisei Y | Biocontrol Sci | 10.4265/bio.26.43 | 2021 | | |
| Comparative Study of the Antimicrobial Activity of Selenium Nanoparticles With Different Surface Chemistry and Structure. | Filipovic N, Usjak D, Milenkovic MT, Zheng K, Liverani L, Boccaccini AR, Stevanovic MM | Front Bioeng Biotechnol | 10.3389/fbioe.2020.624621 | 2021 | | |
| Pathogenicity | Semi-synthesis of N-alkyl-kappa-carrageenan derivatives and evaluation of their antibacterial activity. | Junior EH, Goncalves AG, Noseda MD, Duarte MER, Murakami FS, Ducatti DRB | Carbohydr Res | 10.1016/j.carres.2021.108234 | 2021 | |
| Pathogenicity | Biomedical Applications of Mycosynthesized Selenium Nanoparticles Using Penicillium expansum ATTC 36200. | Hashem AH, Khalil AMA, Reyad AM, Salem SS | Biol Trace Elem Res | 10.1007/s12011-020-02506-z | 2021 | |
| Evaluation of antibacterial activity of enterocin A-colicin E1 fusion peptide. | Fathizadeh H, Saffari M, Esmaeili D, Moniri R, Salimian M | Iran J Basic Med Sci | 10.22038/ijbms.2020.47826.11004 | 2020 | | |
| Activity of Temporin A and Short Lipopeptides Combined with Gentamicin against Biofilm Formed by Staphylococcus aureus and Pseudomonas aeruginosa. | Paduszynska MA, Greber KE, Paduszynski W, Sawicki W, Kamysz W | Antibiotics (Basel) | 10.3390/antibiotics9090566 | 2020 | | |
| The outlier Pseudomonas aeruginosa strain ATCC 9027 harbors a defective LasR quorum-sensing transcriptional regulator. | Garcia-Reyes S, Soto-Aceves MP, Cocotl-Yanez M, Gonzalez-Valdez A, Servin-Gonzalez L, Chavez GS | FEMS Microbiol Lett | 10.1093/femsle/fnaa122 | 2020 | | |
| Survival strategy of Pseudomonas aeruginosa on the nanopillar topography of dragonfly (Pantala flavescens) wing. | Kamarajan BP, Muthusamy A | AMB Express | 10.1186/s13568-020-01021-7 | 2020 | | |
| Pathogenicity | Antimicrobial and Antibiofilm Activity of Lys-[Trp6]hy-a1 Combined with Ciprofloxacin Against Gram-Negative Bacteria. | Carneiro VA, de Oliveira ST, Silva RL, de Sousa Duarte H, Silva ML, Matos MNC, Cavalcante RMB, Figueira CS, Lorenzon EN, Cilli EM, da Cunha RMS | Protein Pept Lett | 10.2174/0929866527666200416145549 | 2020 | |
| Pathogenicity | Synthesis of novel 2, 3, 5-tri-substituted thiazoles with anti-inflammatory and antibacterial effect causing clinical pathogens. | Ahmed A, Molvi KI, Patel HM, Ullah R, Bari A | J Infect Public Health | 10.1016/j.jiph.2020.02.002 | 2020 | |
| Metabolism | Enhancement of Antibacterial Activity of Paludifilum halophilum and Identification of N-(1-Carboxy-ethyl)-phthalamic Acid as the Main Bioactive Compound. | Frikha-Dammak D, Fakhfakh J, Belhaj D, Bouattour E, Ayadi H, Chaabouni M, Ayadi H, Maalej S | Biomed Res Int | 10.1155/2020/4805706 | 2020 | |
| Pathogenicity | Imaging studies of bacterial biofilms on cochlear implants-Bioactive glass (BAG) inhibits mature biofilm. | Kirchhoff L, Arweiler-Harbeck D, Arnolds J, Hussain T, Hansen S, Bertram R, Buer J, Lang S, Steinmann J, Hoing B | PLoS One | 10.1371/journal.pone.0229198 | 2020 | |
| Pathogenicity | Antimicrobial Effectiveness in Eye Drops: Limited Sterility versus Reduction in Microbial Count. | Abu Shaqra QM, Al-Groom RM, Abu Shaqra AQ | PDA J Pharm Sci Technol | 10.5731/pdajpst.2019.009845 | 2020 | |
| Prevention of Pseudomonas aeruginosa Biofilm Formation on Soft Contact Lenses by Allium sativum Fermented Extract (BGE) and Cannabinol Oil Extract (CBD). | Di Onofrio V, Gesuele R, Maione A, Liguori G, Liguori R, Guida M, Nigro R, Galdiero E | Antibiotics (Basel) | 10.3390/antibiotics8040258 | 2019 | | |
| Metabolism | Rapid and solitary production of mono-rhamnolipid biosurfactant and biofilm inhibiting pyocyanin by a taxonomic outlier Pseudomonas aeruginosa strain CR1. | Sood U, Singh DN, Hira P, Lee JK, Kalia VC, Lal R, Shakarad M | J Biotechnol | 10.1016/j.jbiotec.2019.11.004 | 2019 | |
| Influence of Short Cationic Lipopeptides with Fatty Acids of Different Chain Lengths on Bacterial Biofilms Formed on Polystyrene and Hydrogel Surfaces. | Paduszynska MA, Maciejewska M, Neubauer D, Golacki K, Szymukowicz M, Bauer M, Kamysz W | Pharmaceutics | 10.3390/pharmaceutics11100506 | 2019 | | |
| Metabolism | Functional roles of norCB in Pseudomonas aeruginosa ATCC 9027 under aerobic conditions. | Zhou G, Wang YS, Peng H, Shen PF, Xie XB, Shi QS | J Basic Microbiol | 10.1002/jobm.201900267 | 2019 | |
| Enzymology | Biological functions of nirS in Pseudomonas aeruginosa ATCC 9027 under aerobic conditions. | Zhou G, Peng H, Wang YS, Li CL, Shen PF, Huang XM, Xie XB, Shi QS | J Ind Microbiol Biotechnol | 10.1007/s10295-019-02232-z | 2019 | |
| Enhanced synergistic effects of xylitol and isothiazolones for inhibition of initial biofilm formation by Pseudomonas aeruginosa ATCC 9027 and Staphylococcus aureus ATCC 6538. | Zhou G, Peng H, Wang YS, Huang XM, Xie XB, Shi QS | J Oral Sci | 10.2334/josnusd.18-0102 | 2019 | | |
| Antibacterial activity of lysozyme-chitosan oligosaccharide conjugates (LYZOX) against Pseudomonas aeruginosa, Acinetobacter baumannii and Methicillin-resistant Staphylococcus aureus. | Saito H, Sakakibara Y, Sakata A, Kurashige R, Murakami D, Kageshima H, Saito A, Miyazaki Y | PLoS One | 10.1371/journal.pone.0217504 | 2019 | | |
| Pathogenicity | Colorimetric microdilution assay: Validation of a standard method for determination of MIC, IC50%, and IC90% of antimicrobial compounds. | Veiga A, Toledo MDGT, Rossa LS, Mengarda M, Stofella NCF, Oliveira LJ, Goncalves AG, Murakami FS | J Microbiol Methods | 10.1016/j.mimet.2019.05.003 | 2019 | |
| Pathogenicity | Chemical Composition and Antimicrobial Activity of Laurus nobilis L. Essential Oils from Bulgaria. | Fidan H, Stefanova G, Kostova I, Stankov S, Damyanova S, Stoyanova A, Zheljazkov VD | Molecules | 10.3390/molecules24040804 | 2019 | |
| Design, synthesis, and biological activity of novel ammonium salts containing sterically hindered phenolic fragment and phosphoryl group. | Starodubtseva RR, Gibadullina EM, Pazilova NB, Sapunova AS, Voloshina AD, Sudakov IA, Vyshtakalyuk AB, Pudovik MA, Burilov AR, Bukharov SV | Medchemcomm | 10.1039/c8md00481a | 2018 | | |
| Total Phenolic Content and Antioxidant and Antibacterial Activities of Pereskia bleo. | Johari MA, Khong HY | Adv Pharmacol Sci | 10.1155/2019/7428593 | 2019 | | |
| Pathogenicity | Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study. | Mangiaterra G, Amiri M, Di Cesare A, Pasquaroli S, Manso E, Cirilli N, Citterio B, Vignaroli C, Biavasco F | BMC Infect Dis | 10.1186/s12879-018-3612-9 | 2018 | |
| Pathogenicity | N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation. | Asadipour A, Moshafi MH, Khosravani L, Moghimi S, Amou E, Firoozpour L, Ilbeigi G, Beiki K, Soleimani E, Foroumadi A | Daru | 10.1007/s40199-018-0226-0 | 2018 | |
| Bioactive Glass Granules Inhibit Mature Bacterial Biofilms on the Surfaces of Cochlear Implants. | Hoing B, Kirchhoff L, Arnolds J, Hussain T, Buer J, Lang S, Arweiler-Harbeck D, Steinmann J | Otol Neurotol | 10.1097/MAO.0000000000002021 | 2018 | | |
| Metabolism | Overproduction of rhamnolipids in Pseudomonas aeruginosa PA14 by redirection of the carbon flux from polyhydroxyalkanoate synthesis and overexpression of the rhlAB-R operon. | Gutierrez-Gomez U, Soto-Aceves MP, Servin-Gonzalez L, Soberon-Chavez G | Biotechnol Lett | 10.1007/s10529-018-2610-8 | 2018 | |
| Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics. | Consoli GML, Granata G, Picciotto R, Blanco AR, Geraci C, Marino A, Nostro A | Medchemcomm | 10.1039/c7md00527j | 2017 | | |
| Pathogenicity | Experimental approach for a possible integrated protocol to determine sanitizer activity against both planktonic bacteria and related biofilms. | Campana R, Ciandrini E, Baffone W | Food Res Int | 10.1016/j.foodres.2018.05.067 | 2018 | |
| Macroalgae Extracts From Antarctica Have Antimicrobial and Anticancer Potential. | Martins RM, Nedel F, Guimaraes VBS, da Silva AF, Colepicolo P, de Pereira CMP, Lund RG | Front Microbiol | 10.3389/fmicb.2018.00412 | 2018 | | |
| Genetics | Draft Genome Sequence of Pseudomonas aeruginosa ATCC 9027, Originally Isolated from an Outer Ear Infection. | Jayal A, Johns BE, Purdy KJ, Maddocks SE | Genome Announc | 10.1128/genomeA.01397-17 | 2017 | |
| Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin. | Masadeh MM, Alzoubi KH, Al-Azzam SI, Al-Buhairan AM | Clin Pharmacol | 10.2147/CPAA.S148448 | 2017 | | |
| Effect of low-concentration rhamnolipid biosurfactant on Pseudomonas aeruginosa transport in natural porous media. | Liu G, Zhong H, Jiang Y, Brusseau ML, Huang J, Shi L, Liu Z, Liu Y, Zeng G | Water Resour Res | 10.1002/2016WR019832 | 2017 | | |
| Synergistic effect of Carum copticum and Mentha piperita essential oils with ciprofloxacin, vancomycin, and gentamicin on Gram-negative and Gram-positive bacteria. | Talei GR, Mohammadi M, Bahmani M, Kopaei MR | Int J Pharm Investig | 10.4103/jphi.JPHI_12_17 | 2017 | | |
| Pathogenicity | Inhibition of bacterial biofilms by carboxymethyl chitosan combined with silver, zinc and copper salts. | Goncalves RC, da Silva DP, Signini R, Naves PLF | Int J Biol Macromol | 10.1016/j.ijbiomac.2017.07.048 | 2017 | |
| Evolution of Aggregate Structure in Solutions of Anionic Monorhamnolipids: Experimental and Computational Results. | Eismin RJ, Munusamy E, Kegel LL, Hogan DE, Maier RM, Schwartz SD, Pemberton JE | Langmuir | 10.1021/acs.langmuir.7b00078 | 2017 | | |
| Pathogenicity | In Vitro Evaluation of the Antioxidant, Cytoprotective, and Antimicrobial Properties of Essential Oil from Pistacia vera L. Variety Bronte Hull. | Smeriglio A, Denaro M, Barreca D, Calderaro A, Bisignano C, Ginestra G, Bellocco E, Trombetta D | Int J Mol Sci | 10.3390/ijms18061212 | 2017 | |
| Metabolism | A deletion mutation in nfxB of in vitro-induced moxifloxacin-resistant Pseudomonas aeruginosa confers multidrug resistance. | Thai VC, Pham HV, Nguyen DNM, Lambert P, Nguyen TTH | Acta Microbiol Immunol Hung | 10.1556/030.64.2017.012 | 2017 | |
| Pathogenicity | Efficacy of benzalkonium chloride against bioluminescent P. aeruginosa ATCC9027 constructs. | Shah N, Naseby DC | Biosens Bioelectron | 10.1016/j.bios.2017.04.029 | 2017 | |
| Pathogenicity | Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo Dragon) by Large-Scale Analyses and De-Novo-Assisted Sequencing Using Electron-Transfer Dissociation Mass Spectrometry. | Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML | J Proteome Res | 10.1021/acs.jproteome.6b00857 | 2017 | |
| Metabolism | Effect of rhamnolipid solubilization on hexadecane bioavailability: enhancement or reduction? | Liu Y, Zeng G, Zhong H, Wang Z, Liu Z, Cheng M, Liu G, Yang X, Liu S | J Hazard Mater | 10.1016/j.jhazmat.2016.10.025 | 2016 | |
| Pathogenicity | A bioactivity guided study on the antibacterial activity of Hertia cheirifolia L. extracts. | Majouli K, Hamdi A, Msaada K, Kenani A | Microb Pathog | 10.1016/j.micpath.2016.10.015 | 2016 | |
| Metabolism | Pseudomonas aeruginosa ATCC 9027 is a non-virulent strain suitable for mono-rhamnolipids production. | Grosso-Becerra MV, Gonzalez-Valdez A, Granados-Martinez MJ, Morales E, Servin-Gonzalez L, Mendez JL, Delgado G, Morales-Espinosa R, Ponce-Soto GY, Cocotl-Yanez M, Soberon-Chavez G | Appl Microbiol Biotechnol | 10.1007/s00253-016-7789-9 | 2016 | |
| Pathogenicity | Antimicrobial evaluation of selected naturally occurring oxyprenylated secondary metabolites. | Di Giulio M, Genovese S, Fiorito S, Epifano F, Nostro A, Cellini L | Nat Prod Res | 10.1080/14786419.2015.1079908 | 2015 | |
| Pathogenicity | A bactericidal calix[4]arene-based nanoconstruct with amplified NO photorelease. | Di Bari I, Picciotto R, Granata G, Blanco AR, Consoli GM, Sortino S | Org Biomol Chem | 10.1039/c6ob01305h | 2016 | |
| Pathogenicity | Modulation of antibiotic resistance in Pseudomonas aeruginosa by ZnO nanoparticles. | Bayroodi E, Jalal R | Iran J Microbiol | 2016 | | |
| Comparison of the compact dry TC method with the standard method ISO 21149:2006 for determining aerobic colony counts in cosmetic emulsion. | De Vaugelade S, Aime M, Farcette N, Maurel E, Lacour T, Thomas C, Bouchonnet S, Pirnay S | Int J Cosmet Sci | 10.1111/ics.12343 | 2016 | | |
| Pathogenicity | Effect of Mono and Di-rhamnolipids on Biofilms Pre-formed by Bacillus subtilis BBK006. | De Rienzo MA, Martin PJ | Curr Microbiol | 10.1007/s00284-016-1046-4 | 2016 | |
| Ciprofloxacin-Induced Antibacterial Activity Is Atteneuated by Pretreatment with Antioxidant Agents. | Masadeh MM, Alzoubi KH, Al-Azzam SI, Khabour OF, Al-Buhairan AM | Pathogens | 10.3390/pathogens5010028 | 2016 | | |
| Pathogenicity | A novel approach to antibiofilm susceptibility testing using a thermo-reversible matrix. | Taylor BJ, Marsh LL, Nosworthy JO, Williams DW | J Wound Care | 10.12968/jowc.2016.25.2.62 | 2016 | |
| Antimicrobial activities of endophytic fungi of the Sri Lankan aquatic plant Nymphaea nouchali and chaetoglobosin A and C, produced by the endophytic fungus Chaetomium globosum. | Dissanayake RK, Ratnaweera PB, Williams DE, Wijayarathne CD, Wijesundera RLC, Andersen RJ, de Silva ED | Mycology | 10.1080/21501203.2015.1136708 | 2016 | | |
| Pathogenicity | Effect of low-concentration rhamnolipid on transport of Pseudomonas aeruginosa ATCC 9027 in an ideal porous medium with hydrophilic or hydrophobic surfaces. | Zhong H, Liu G, Jiang Y, Brusseau ML, Liu Z, Liu Y, Zeng G | Colloids Surf B Biointerfaces | 10.1016/j.colsurfb.2015.11.024 | 2015 | |
| Pathogenicity | Inhibitory Effects of 2,2'-Dipyridyl and 1,2,3,4,6-Penta-O-Galloyl-b-D-Glucopyranose on Biofilm Formation in Contact Lens Cases. | Cho P, Shi GS, Boost M | Invest Ophthalmol Vis Sci | 10.1167/iovs.15-17723 | 2015 | |
| Genetics | Draft Genome Sequence of Pseudomonas aeruginosa ATCC 9027 (DSM 1128), an Important Rhamnolipid Surfactant Producer and Sterility Testing Strain. | Mai-Prochnow A, Bradbury M, Murphy AB | Genome Announc | 10.1128/genomeA.01259-15 | 2015 | |
| Metabolism | Biosurfactant production by Pseudomonas aeruginosain kefir and fish meal. | Kaskatepe B, Yildiz S, Gumustas M, Ozkan SA | Braz J Microbiol | 10.1590/S1517-838246320140727 | 2015 | |
| Enzymology | Microbial spoilage, instability risk of antacid suspension in the presence of commonly used preservative system. | Khan JA, Khan IU, Iqbal Z, Nasir F, Muhammad S, Hannan PA, Ullah I | Pak J Pharm Sci | 2015 | | |
| Pathogenicity | Identification of an antibacterial protein by functional screening of a human oral metagenomic library. | Arivaradarajan P, Warburton PJ, Paramasamy G, Nair SP, Allan E, Mullany P | FEMS Microbiol Lett | 10.1093/femsle/fnv142 | 2015 | |
| Pathogenicity | Synthesis, electronic properties, antioxidant and antibacterial activity of some new benzimidazoles. | Mavrova ATs, Yancheva D, Anastassova N, Anichina K, Zvezdanovic J, Djordjevic A, Markovic D, Smelcerovic A | Bioorg Med Chem | 10.1016/j.bmc.2015.08.029 | 2015 | |
| Corneal Biofilms: From Planktonic to Microcolony Formation in an Experimental Keratitis Infection with Pseudomonas Aeruginosa. | Saraswathi P, Beuerman RW | Ocul Surf | 10.1016/j.jtos.2015.07.001 | 2015 | | |
| Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance. | Ayaz M, Subhan F, Ahmed J, Khan AU, Ullah F, Ullah I, Ali G, Syed NI, Hussain S | J Biol Res (Thessalon) | 10.1186/s40709-015-0028-1 | 2015 | | |
| Enzymology | Rapid identification of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. | Selim S, El Kholy I, Hagagy N, El Alfay S, Aziz MA | Biotechnol Biotechnol Equip | 10.1080/13102818.2014.981065 | 2014 | |
| Metabolism | Effects of biosurfactant-producing bacteria on biodegradation and transport of phenanthrene in subsurface soil. | Chang JS, Cha DK, Radosevich M, Jin Y | J Environ Sci Health A Tox Hazard Subst Environ Eng | 10.1080/10934529.2015.994967 | 2015 | |
| Pathogenicity | Expression of recombinant Arabian camel lactoferricin-related peptide in Pichia pastoris and its antimicrobial identification. | Chahardooli M, Niazi A, Aram F, Sohrabi SM | J Sci Food Agric | 10.1002/jsfa.7125 | 2015 | |
| Enzymology | Validation of constitutively expressed bioluminescent Pseudomonas aeruginosa as a rapid microbiological quantification tool. | Shah N, Naseby DC | Biosens Bioelectron | 10.1016/j.bios.2015.01.008 | 2015 | |
| Metabolism | Effect of low-concentration rhamnolipid on adsorption of Pseudomonas aeruginosa ATCC 9027 on hydrophilic and hydrophobic surfaces. | Zhong H, Jiang Y, Zeng G, Liu Z, Liu L, Liu Y, Yang X, Lai M, He Y | J Hazard Mater | 10.1016/j.jhazmat.2014.11.050 | 2014 | |
| Proteome | Insights into Pseudomonas aeruginosa ATCC9027 resistance to isothiazolones through proteomics. | Zhou G, Shi QS, Huang XM, Xie XB, Chen YB | Microb Drug Resist | 10.1089/mdr.2014.0113 | 2014 | |
| Biotechnology | Assessment of tolerance induction by Origanum vulgare L. essential oil or carvacrol in Pseudomonas aeruginosa cultivated in a meat-based broth and in a meat model. | da Silva Luz I, Gomes-Neto NJ, Magnani M, de Souza EL | Food Sci Technol Int | 10.1177/1082013214554467 | 2014 | |
| Bioluminescence-based measurement of viability of Pseudomonas aeruginosa ATCC 9027 harbouring plasmid-based lux genes under the control of constitutive promoters. | Shah N, Naseby DC | J Appl Microbiol | 10.1111/jam.12635 | 2014 | | |
| Pathogenicity | Manuka honey treatment of biofilms of Pseudomonas aeruginosa results in the emergence of isolates with increased honey resistance. | Camplin AL, Maddocks SE | Ann Clin Microbiol Antimicrob | 10.1186/1476-0711-13-19 | 2014 | |
| Green synthesis of silver nanoparticles using Delphinium denudatum root extract exhibits antibacterial and mosquito larvicidal activities. | Suresh G, Gunasekar PH, Kokila D, Prabhu D, Dinesh D, Ravichandran N, Ramesh B, Koodalingam A, Vijaiyan Siva G | Spectrochim Acta A Mol Biomol Spectrosc | 10.1016/j.saa.2014.02.030 | 2014 | | |
| Metabolism | Statistical screening of medium components for recombinant production of Pseudomonas aeruginosa ATCC 9027 rhamnolipids by nonpathogenic cell factory Pseudomonas putida KT2440. | Setoodeh P, Jahanmiri A, Eslamloueyan R, Niazi A, Ayatollahi SS, Aram F, Mahmoodi M, Hortamani A | Mol Biotechnol | 10.1007/s12033-013-9693-1 | 2014 | |
| Pathogenicity | Cis-9-octadecenoic acid from the rhizospheric bacterium Stenotrophomonas maltophilia BJ01 shows quorum quenching and anti-biofilm activities. | Singh VK, Kavita K, Prabhakaran R, Jha B | Biofouling | 10.1080/08927014.2013.807914 | 2013 | |
| Metabolism | Use of a greasy effluent floater treatment station from the slaughterhouse for biosurfactant production. | Borges Wda S, Cardoso VL, de Resende MM | Biotechnol Appl Biochem | 10.1002/bab.1018 | 2012 | |
| Metabolism | Biochemical characterization and evaluation of potent inhibitors of the Pseudomonas aeruginosa PA01 acetohydroxyacid synthase. | Cho JH, Lee MY, Baig IA, Ha NR, Kim J, Yoon MY | Biochimie | 10.1016/j.biochi.2013.03.007 | 2013 | |
| Pathogenicity | Antimicrobial activity of blended essential oil preparation. | Tadtong S, Suppawat S, Tintawee A, Saramas P, Jareonvong S, Hongratanaworakit T | Nat Prod Commun | 2012 | | |
| Pathogenicity | In-vivo and in-vitro biocompatibility evaluations of silver nanoparticles with antimicrobial activity. | Han DW, Woo YI, Lee MH, Lee JH, Lee J, Park JC | J Nanosci Nanotechnol | 10.1166/jnn.2012.6367 | 2012 | |
| Pathogenicity | Synthesis and characterization of some new complexes of Cu(II), Ni(II) and V(IV) with Schiff base derived from indole-3-carboxaldehyde. Biological activity on prokaryotes and eukaryotes. | Rosu T, Pahontu E, Ilies DC, Georgescu R, Mocanu M, Leabu M, Shova S, Gulea A | Eur J Med Chem | 10.1016/j.ejmech.2012.03.046 | 2012 | |
| Pathogenicity | Semisynthesis and antimicrobial activity of novel guttiferone-A derivatives. | Dias KS, Januario JP, D' Dego JL, Dias AL, dos Santos MH, Camps I, Coelho LF, Viegas C Jr | Bioorg Med Chem | 10.1016/j.bmc.2012.02.023 | 2012 | |
| Pathogenicity | Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7. | Morita Y, Tomida J, Kawamura Y | Microbiology (Reading) | 10.1099/mic.0.054320-0 | 2012 | |
| Pathogenicity | Contact lens disinfecting solutions antibacterial efficacy: comparison between clinical isolates and the standard ISO ATCC strains of Pseudomonas aeruginosa and Staphylococcus aureus. | Mohammadinia M, Rahmani S, Eslami G, Ghassemi-Broumand M, Aghazadh Amiri M, Aghaie G, Tabatabaee SM, Taheri S, Behgozin A | Eye (Lond) | 10.1038/eye.2011.284 | 2011 | |
| Pathogenicity | In vitro assay of the antimicrobial activity of kephir against bacterial and fungal strains. | Chifiriuc MC, Cioaca AB, Lazar V | Anaerobe | 10.1016/j.anaerobe.2011.04.020 | 2011 | |
| Pathogenicity | Importance of rub and rinse in use of multipurpose contact lens solution. | Zhu H, Bandara MB, Vijay AK, Masoudi S, Wu D, Willcox MD | Optom Vis Sci | 10.1097/OPX.0b013e31821bf976 | 2011 | |
| Pathogenicity | The influence of nanoscopically thin silver films on bacterial viability and attachment. | Ivanova EP, Hasan J, Truong VK, Wang JY, Raveggi M, Fluke C, Crawford RJ | Appl Microbiol Biotechnol | 10.1007/s00253-011-3195-5 | 2011 | |
| Pathogenicity | Hydroalcoholic extract based-ointment from Punica granatum L. peels with enhanced in vivo healing potential on dermal wounds. | Hayouni EA, Miled K, Boubaker S, Bellasfar Z, Abedrabba M, Iwaski H, Oku H, Matsui T, Limam F, Hamdi M | Phytomedicine | 10.1016/j.phymed.2011.02.011 | 2011 | |
| Pathogenicity | Comparative efficacies of contact lens disinfecting solutions against Pseudomonas aeruginosa. | Amiri MA, Mohammadinia M, Tabatabaee M, Askarizadeh F, Behgozin A | Clin Exp Optom | 10.1111/j.1444-0938.2010.00576.x | 2011 | |
| Metabolism | Effects of rhamnolipids on cell surface hydrophobicity of PAH degrading bacteria and the biodegradation of phenanthrene. | Zhao Z, Selvam A, Wong JW | Bioresour Technol | 10.1016/j.biortech.2010.11.088 | 2010 | |
| [Structural components and peculiarities of Pseudomonas aeruginosa biofilm organization]. | Balko OB, Avdieieva LV | Mikrobiol Z | 2010 | | ||
| Pathogenicity | P(4-VP) based nanoparticles and composites with dual action as antimicrobial materials. | Ozay O, Akcali A, Otkun MT, Silan C, Aktas N, Sahiner N | Colloids Surf B Biointerfaces | 10.1016/j.colsurfb.2010.05.013 | 2010 | |
| Pathogenicity | Antimicrobial and antioxidant activities of Mexican oregano essential oils (Lippia graveolens H. B. K.) with different composition when microencapsulated in beta-cyclodextrin. | Arana-Sanchez A, Estarron-Espinosa M, Obledo-Vazquez EN, Padilla-Camberos E, Silva-Vazquez R, Lugo-Cervantes E | Lett Appl Microbiol | 10.1111/j.1472-765X.2010.02837.x | 2010 | |
| Pathogenicity | New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation. | Almajan GL, Barbuceanu SF, Saramet I, Draghici C | Eur J Med Chem | 10.1016/j.ejmech.2010.02.057 | 2010 | |
| Genetics | Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7. | Roy PH, Tetu SG, Larouche A, Elbourne L, Tremblay S, Ren Q, Dodson R, Harkins D, Shay R, Watkins K, Mahamoud Y, Paulsen IT | PLoS One | 10.1371/journal.pone.0008842 | 2010 | |
| Pathogenicity | In vitro synergistic activities of essential oils and surfactants in combination with cosmetic preservatives against Pseudomonas aeruginosa and Staphylococcus aureus. | Patrone V, Campana R, Vittoria E, Baffone W | Curr Microbiol | 10.1007/s00284-009-9531-7 | 2009 | |
| Pathogenicity | Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties. | Barbuceanu SF, Almajan GL, Saramet I, Draghici C, Tarcomnicu AI, Bancescu G | Eur J Med Chem | 10.1016/j.ejmech.2009.06.021 | 2009 | |
| Pathogenicity | Antimicrobial activity of lavender, tea tree and lemon oils in cosmetic preservative systems. | Kunicka-Styczynska A, Sikora M, Kalemba D | J Appl Microbiol | 10.1111/j.1365-2672.2009.04372.x | 2009 | |
| Pathogenicity | Copper(II) and uranyl(II) complexes with acylthiosemicarbazide: synthesis, characterization, antibacterial activity and effects on the growth of promyelocytic leukemia cells HL-60. | Angelusiu MV, Almajan GL, Rosu T, Negoiu M, Almajan ER, Roy J | Eur J Med Chem | 10.1016/j.ejmech.2009.03.016 | 2009 | |
| Enzymology | [Microbiological contamination and antimicrobial activity of cristalised cane sugar on some medically important microorganisms in Costa Rica]. | Pujol V, Diaz J, Rodriguez E, Arias ML | Rev Biol Trop | 2008 | | |
| Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus attachment patterns on glass surfaces with nanoscale roughness. | Mitik-Dineva N, Wang J, Truong VK, Stoddart P, Malherbe F, Crawford RJ, Ivanova EP | Curr Microbiol | 10.1007/s00284-008-9320-8 | 2008 | | |
| Pathogenicity | Synthesis, characterization and antibacterial activity of some triazole Mannich bases carrying diphenylsulfone moieties. | Almajan GL, Barbuceanu SF, Almajan ER, Draghici C, Saramet G | Eur J Med Chem | 10.1016/j.ejmech.2008.07.003 | 2008 | |
| Pathogenicity | Novel lipid and preservative-free propofol formulation: properties and pharmacodynamics. | Ravenelle F, Gori S, Le Garrec D, Lessard D, Luo L, Palusova D, Sneyd JR, Smith D | Pharm Res | 10.1007/s11095-007-9471-5 | 2007 | |
| Metabolism | Production and characterization of polyhydroxyalkanoates in Pseudomonas aeruginosa ATCC 9027 from glucose, an unrelated carbon source. | Rojas-Rosas O, Villafana-Rojas J, Lopez-Dellamary FA, Nungaray-Arellano J, Gonzalez-Reynoso O | Can J Microbiol | 10.1139/W07-023 | 2007 | |
| Pathogenicity | [Investigation of the efficacy of electrolyzed acid water on the standard strains of some pathogenic microorganisms]. | Ileri C, Sezen Y, Dimoglo A | Mikrobiyol Bul | 2006 | | |
| Enzymology | Determination of the acid dissociation constant of the biosurfactant monorhamnolipid in aqueous solution by potentiometric and spectroscopic methods. | Lebron-Paler A, Pemberton JE, Becker BA, Otto WH, Larive CK, Maier RM | Anal Chem | 10.1021/ac0608826 | 2006 | |
| Enzymology | Enhanced aqueous solubilization of tetrachloroethylene by a rhamnolipid biosurfactant. | Clifford JS, Ioannidis MA, Legge RL | J Colloid Interface Sci | 10.1016/j.jcis.2006.10.026 | 2006 | |
| Pathogenicity | [Microbiological assessment of efficiency of antibacterial modified textiles]. | Jakimiak B, Rohm-Rodowald E, Staniszewska M, Cieslak M, Malinowska G, Kaleta A | Rocz Panstw Zakl Hig | 2006 | | |
| Pathogenicity | Microbiological study of cosmetic products during their use by consumers: health risk and efficacy of preservative systems. | Campana R, Scesa C, Patrone V, Vittoria E, Baffone W | Lett Appl Microbiol | 10.1111/j.1472-765X.2006.01952.x | 2006 | |
| Enzymology | Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model. | Chan E, Zhou S, Srikumar S, Duan W | Pharm Res | 10.1007/s11095-006-9783-x | 2006 | |
| Pathogenicity | Antimicrobial preservative effectiveness of natural peptide antibiotics. | Kamysz W, Turecka K | Acta Pol Pharm | 2005 | | |
| Biotechnology | [Evaluation of the antimicrobial action of honey against Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Escherichia coli, Salmonella enteritidis, Listeria monocytogenes and Aspergillus niger. Evaluation of its microbiological charge]. | Estrada H, Gamboa Mdel M, Arias ML, Chaves C | Arch Latinoam Nutr | 2005 | | |
| Metabolism | Monitoring microaerobic denitrification of Pseudomonas aeruginosa by online NAD(P)H fluorescence. | Ju LK, Chen F, Xia Q | J Ind Microbiol Biotechnol | 10.1007/s10295-005-0035-6 | 2005 | |
| Pathogenicity | Allylthiosulfinate: beta-cyclodextrin inclusion complex: preparation, characterization and microbiological activity. | Nikolic V, Stankovic M, Kapor A, Nikolic Lj, Cvetkovic D, Stamenkovic J | Pharmazie | 2004 | | |
| Enzymology | Solubilization and desorption of PAHs in soil-aqueous system by biosurfactants produced from Pseudomonas aeruginosa P-CG3 under thermophilic condition. | Cheng KY, Zhao ZY, Wong JW | Environ Technol | 10.1080/09593332508618382 | 2004 | |
| Metabolism | Effect of surfactants on solubilization and degradation of phenanthrene under thermophilic conditions. | Wong JW, Fang M, Zhao Z, Xing B | J Environ Qual | 10.2134/jeq2004.2015 | 2004 | |
| Enzymology | Cadmium removal from contaminated soil by tunable biopolymers. | Prabhukumar G, Matsumoto M, Mulchandani A, Chen W | Environ Sci Technol | 10.1021/es035150z | 2004 | |
| Pathogenicity | Preliminary evaluation of bioactive glass S53P4 as an endodontic medication in vitro. | Zehnder M, Soderling E, Salonen J, Waltimo T | J Endod | 10.1097/00004770-200404000-00009 | 2004 | |
| Metabolism | Structure and characterization of flavolipids, a novel class of biosurfactants produced by Flavobacterium sp. strain MTN11. | Bodour AA, Guerrero-Barajas C, Jiorle BV, Malcomson ME, Paull AK, Somogyi A, Trinh LN, Bates RB, Maier RM | Appl Environ Microbiol | 10.1128/AEM.70.1.114-120.2004 | 2004 | |
| Metabolism | Aerobic denitrification of Pseudomonas aeruginosa monitored by online NAD(P)H fluorescence. | Chen F, Xia Q, Ju LK | Appl Environ Microbiol | 10.1128/AEM.69.11.6715-6722.2003 | 2003 | |
| Pathogenicity | Antibacterial activity of intraocularly used liquids against two strains of Pseudomonas aeruginosa. | Economou-Stamatelopoulou C, Roussopoulos GP, Prouskas JC, Apostolopoulos M | Ophthalmologica | 10.1159/000073074 | 2003 | |
| Metabolism | Phenanthrene degradation in soils co-inoculated with phenanthrene-degrading and biosurfactant-producing bacteria. | Dean SM, Jin Y, Cha DK, Wilson SV, Radosevich M | J Environ Qual | 10.2134/jeq2001.3041126x | 2001 | |
| Pathogenicity | Comparative responses of Pseudomonas stutzeri and Pseudomonas aeruginosa to antibacterial agents. | Tattawasart U, Maillard JY, Furr JR, Russell AD | J Appl Microbiol | 10.1046/j.1365-2672.1999.00811.x | 1999 | |
| Pathogenicity | Electron-microscopic study of the bactericidal effect of OPB-2045, a new mono-biguanide disinfectant produced from biguanide group compounds, against Pseudomonas aeruginosa. | Sakagami Y, Mimura M, Kajimura K, Yokoyama H, Nishimura H | J Pharm Pharmacol | 10.1211/0022357991772141 | 1999 | |
| Genetics | Structural and functional implications of sequence diversity of Pseudomonas aeruginosa genes oriC, ampC and fliC. | Spangenberg C, Montie TC, Tummler B | Electrophoresis | 10.1002/elps.1150190414 | 1998 | |
| Metabolism | Evaluation of the biological containment system based on the Escherichia coli gef gene in Pseudomonas aeruginosa W51D. | Soberon-Chavez G | Appl Microbiol Biotechnol | 10.1007/s002530050859 | 1996 | |
| Enzymology | Biosurfactant-facilitated remediation of metal-contaminated soils. | Miller RM | Environ Health Perspect | 10.1289/ehp.95103s159 | 1995 | |
| Metabolism | Enhanced octadecane dispersion and biodegradation by a Pseudomonas rhamnolipid surfactant (biosurfactant). | Zhang Y, Miller RM | Appl Environ Microbiol | 10.1128/aem.58.10.3276-3282.1992 | 1992 | |
| Biotechnology | [Microbial growth in parenteral nutrition. II. Effects of osmolality]. | Vilchez Medina T, Montero Herrero CG, Garcia Curiel A, Lluch Colomer A, Rodriguez Cobacho A, Atienza Fernandez M | Nutr Hosp | 1990 | | |
| Direct contact membrane method for evaluating preservative efficacy in solid cosmetics. | Tran AT, Hitchins AD, Collier SW | Int J Cosmet Sci | 10.1111/j.1467-2494.1990.tb00533.x | 1990 | | |
| Enzymology | [A microbial growth study in parenteral nutrition]. | Vilchez Medina T, Montero Herrero CG, Garcia Curiel A, Atienza Fernandez M | Nutr Hosp | 1989 | | |
| Metabolism | Amikacin disrupts the cell envelope of Pseudomonas aeruginosa ATCC 9027. | Walker SG, Beveridge TJ | Can J Microbiol | 10.1139/m88-003 | 1988 | |
| Pathogenicity | Gentamicin interaction with Pseudomonas aeruginosa cell envelope. | Martin NL, Beveridge TJ | Antimicrob Agents Chemother | 10.1128/AAC.29.6.1079 | 1986 | |
| Metabolism | Lipopolysaccharide changes and cytoplasmic polyphosphate granule accumulation in Pseudomonas aeruginosa during growth on hexadecane. | Miguez CB, Beveridge TJ, Ingram JM | Can J Microbiol | 10.1139/m86-049 | 1986 | |
| Phylogeny | Spectral properties of a mixture of fluorescent pigments produced by Pseudomonas aeruginosa. | MacDonald JC, Bishop GG | Biochim Biophys Acta | 10.1016/0304-4165(84)90088-6 | 1984 | |
| Phylogeny | Isolation of a Pseudomonas sp. Which Utilizes the Phosphonate Herbicide Glyphosate. | Moore JK, Braymer HD, Larson AD | Appl Environ Microbiol | 10.1128/aem.46.2.316-320.1983 | 1983 | |
| Enzymology | Glycogen and various other polysaccharides stimulate the formation of exolipase by Pseudomonas aeruginosa. | Schulte G, Bohne L, Winkler U | Can J Microbiol | 10.1139/m82-095 | 1982 | |
| Metabolism | Penetration of the outer membrane of Pseudomonas aeruginosa by synergistic combinations of beta-lactam and aminoglycoside antibiotics. | Scudamore RA, Goldner M | Antimicrob Agents Chemother | 10.1128/AAC.21.6.1007 | 1982 | |
| Metabolism | Limited contribution of the outer-membrane penetration barrier towards intrinsic antibiotic resistance of Pseudomonas aeruginosa. | Scudamore RA, Goldner M | Can J Microbiol | 10.1139/m82-022 | 1982 | |
| Enzymology | Heterogeneity and distribution of lipopolysaccharide in the cell wall of a gram-negative marine bacterium. | DiRienzo JM, Deneke CF, MacLeod RA | J Bacteriol | 10.1128/jb.136.1.148-157.1978 | 1978 | |
| Metabolism | The release and characterization of some periplasm-located enzymes of Pseudomona aeruginosa. | Bhatti AR, DeVoe IW, Ingram JM | Can J Microbiol | 10.1139/m76-211 | 1976 | |
| Pathogenicity | Reduced virulence of Pseudomonas aeruginosa grown in the presence of benzalkonium chloride. | Adair FW, Liauw HL, Geftic SG, Gelzer J | J Clin Microbiol | 10.1128/jcm.1.2.175-179.1975 | 1975 | |
| Cultivation | Release of alkaline phosphatase from cells of Pseudomonas aeruginosa by manipulation of cation concentration and of pH. | Cheng KJ, Ingram JM, Costerton JW | J Bacteriol | 10.1128/jb.104.2.748-753.1970 | 1970 | |
| Metabolism | Amino acid pool formation in Pseudomonas aeruginosa. | Kay WW, Gronlund AF | J Bacteriol | 10.1128/jb.97.1.282-291.1969 | 1969 | |
| Phylogeny | Larval gut microbiome of Pelidnota luridipes (Coleoptera: Scarabaeidae): high bacterial diversity, different metabolic profiles on gut chambers and species with probiotic potential. | Falqueto SA, de Sousa JR, da Silva RC, da Silva GF, Pinheiro DG, Soares MA | World J Microbiol Biotechnol | 10.1007/s11274-022-03387-1 | 2022 | |
| Phytochemical Analysis and Antibacterial Activity of Achillea coarctata Poir. Essential Oils. | Stamenkovic JG, Petrovic GM, Dordevic AS | Chem Biodivers | 10.1002/cbdv.202200578 | 2022 | | |
| Component Composition and Biological Activity of Various Extracts of Onosma gmelinii (Boraginaceae). | Shilov SV, Ustenova GO, Kiyekbayeva LN, Korotetskiy IS, Kudashkina NV, Zubenko NV, Parenova RA, Jumagaziyeva AB, Iskakbayeva ZA, Kenesheva ST | Int J Biomater | 10.1155/2022/4427804 | 2022 | | |
| Defining Exposure Predictors of Meropenem That Are Associated with Improved Survival for Severe Bacterial Infection: A Preclinical PK/PD Study in Sepsis Rat Model. | Wang Y, Liu L, Wu Q, Yin Q, Xie F | Antibiotics (Basel) | 10.3390/antibiotics11111660 | 2022 | | |
| A Multidisciplinary Approach in Examining the Susceptibility to Microbial Attack of Polyacrylic and Polyurethane Resins Used in Art Restoration. | Campana R, Sabatini L, Giorgi L, Pettinari G, Valentini L, Gobbi P | Int J Mol Sci | 10.3390/ijms231911725 | 2022 | | |
| Pathogenicity | Design, synthesis, and biological evaluation of tetrahydroquinoline amphiphiles as membrane-targeting antimicrobials against pathogenic bacteria and fungi. | Liu J, Li H, He Q, Chen K, Chen Y, Zhong R, Li H, Fang S, Liu S, Lin S | Eur J Med Chem | 10.1016/j.ejmech.2022.114734 | 2022 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive12760.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License